SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Maria Papp, Zsuzsanna Vitalis, Istvan Altorjay, Istvan Tornai, Miklos Udvardy, Jolan Harsfalvi, Andras Vida, Janos Kappelmayer, Peter L. Lakatos, Peter Antal-Szalmas, Acute phase proteins in the diagnosis and prediction of cirrhosis associated bacterial infections, Liver International, 2012, 32, 4
  2. 2
    Stelios F. Assimakopoulos, Athanassios C. Tsamandas, Georgios I. Tsiaoussis, Elli Karatza, Christos Triantos, Constantine E. Vagianos, Iris Spiliopoulou, Valeria Kaltezioti, Aristidis Charonis, Vassiliki N. Nikolopoulou, Chrisoula D. Scopa, Konstantinos C. Thomopoulos, Altered intestinal tight junctions’ expression in patients with liver cirrhosis: a pathogenetic mechanism of intestinal hyperpermeability, European Journal of Clinical Investigation, 2012, 42, 4
  3. 3
    Lotte G. van Vlerken, Ellen J. Huisman, Bart van Hoek, Willem Renooij, Felix W. M. de Rooij, Peter D. Siersema, Karel J. van Erpecum, Bacterial infections in cirrhosis: role of proton pump inhibitors and intestinal permeability, European Journal of Clinical Investigation, 2012, 42, 6
  4. 4
    Manuela Merli, Cristina Lucidi, Bacterial resistance in cirrhotic patients: An emerging reality, Journal of Hepatology, 2012, 56, 4, 756

    CrossRef

  5. 5
    Derrick E. Fouts, Manolito Torralba, Karen E. Nelson, David A. Brenner, Bernd Schnabl, Bacterial translocation and changes in the intestinal microbiome in mouse models of liver disease, Journal of Hepatology, 2012, 56, 6, 1283

    CrossRef

  6. 6
    Vicente Arroyo, Javier Fernández, Bases fisiopatológicas del uso de la albúmina humana en la cirrosis hepática, Gastroenterología y Hepatología, 2012, 35, 1, 42

    CrossRef

  7. 7
    Zhong-Wen Wu, Zong-Xin Ling, Hai-Feng Lu, Jian Zuo, Ji-Fang Sheng, Shu-Sen Zheng, Lan-Juan Li, Changes of gut bacteria and immune parameters in liver transplant recipients, Hepatobiliary & Pancreatic Diseases International, 2012, 11, 1, 40

    CrossRef

  8. 8
    Jianjun Liu, Dachang Wu, Ayaz Ahmed, Xinli Li, Yufang Ma, Li Tang, Dianjun Mo, Yue Ma, Yi Xin, Comparison of the Gut Microbe Profiles and Numbers Between Patients with Liver Cirrhosis and Healthy Individuals, Current Microbiology, 2012, 65, 1, 7

    CrossRef

  9. 9
    Francesco Corradi, Claudia Brusasco, Javier Fernández, Jordi Vila, Maria Jose Ramirez, Tiago Seva-Pereira, Guillermo Fernández-Varo, Ismail Ben Mosbah, Juan Acevedo, Anibal Silva, Patricia Rieken Macedo Rocco, Paolo Pelosi, Pere Gines, Miquel Navasa, Effects of pentoxifylline on intestinal bacterial overgrowth, bacterial translocation and spontaneous bacterial peritonitis in cirrhotic rats with ascites, Digestive and Liver Disease, 2012, 44, 3, 239

    CrossRef

  10. 10
    Feiqian Wang, Pan Zhang, Hongli Jiang, Shaoli Cheng, Gut Bacterial Translocation Contributes to Microinflammation in Experimental Uremia, Digestive Diseases and Sciences, 2012,

    CrossRef

  11. 11
    Daniel Benten, Reiner Wiest, Gut microbiome and intestinal barrier failure – The “Achilles heel” in hepatology?, Journal of Hepatology, 2012, 56, 6, 1221

    CrossRef

  12. 12
    Craig E. Gordon, Hepatorenal Syndrome, Hospital Medicine Clinics, 2012, 1, 1, e62

    CrossRef

  13. 13
    Cláudia Fagundes, Pere Ginès, Hepatorenal Syndrome: A Severe, but Treatable, Cause of Kidney Failure in Cirrhosis, American Journal of Kidney Diseases, 2012, 59, 6, 874

    CrossRef

  14. 14
    Michael Maes, Marta Kubera, Jean-Claude Leunis, Michael Berk, Increased IgA and IgM responses against gut commensals in chronic depression: Further evidence for increased bacterial translocation or leaky gut, Journal of Affective Disorders, 2012,

    CrossRef

  15. 15
    Zora Teltschik, Reiner Wiest, Julia Beisner, Sabine Nuding, Claudia Hofmann, Juergen Schoelmerich, Charles L. Bevins, Eduard F. Stange, Jan Wehkamp, Intestinal bacterial translocation in rats with cirrhosis is related to compromised paneth cell antimicrobial host defense, Hepatology, 2012, 55, 4
  16. 16
    Javier Fernández, Thierry Gustot, Management of bacterial infections in cirrhosis, Journal of Hepatology, 2012, 56, S1

    CrossRef

  17. 17
    Brian Leonard, Michael Maes, Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression, Neuroscience & Biobehavioral Reviews, 2012, 36, 2, 764

    CrossRef

  18. 18
    C.-C. Shu, J.-T. Wang, J.-Y. Wang, C.-J. Yu, L.-N. Lee, Mycobacterial peritonitis: difference between non-tuberculous mycobacteria and Mycobacterium tuberculosis, Clinical Microbiology and Infection, 2012, 18, 3
  19. 19
    Bledar Kraja, Marsela Sina, Iris Mone, Fatjona Pupuleku, Adriana Babameto, Skerdi Prifti, Genc Burazeri, Predictive Value of the Model of End-Stage Liver Disease in Cirrhotic Patients with and without Spontaneous Bacterial Peritonitis, Gastroenterology Research and Practice, 2012, 2012, 1

    CrossRef

  20. 20
    Dianne H. Dapito, Ali Mencin, Geum-Youn Gwak, Jean-Philippe Pradere, Myoung-Kuk Jang, Ingmar Mederacke, Jorge M. Caviglia, Hossein Khiabanian, Adebowale Adeyemi, Ramon Bataller, Jay H. Lefkowitch, Maureen Bower, Richard Friedman, R. Balfour Sartor, Raul Rabadan, Robert F. Schwabe, Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4, Cancer Cell, 2012, 21, 4, 504

    CrossRef

  21. 21
    S.A. Schmid, R. Wiest, B. Salzberger, F. Klebl, Spontan bakterielle Peritonitis, Medizinische Klinik - Intensivmedizin und Notfallmedizin, 2012,

    CrossRef

  22. 22
    Beate Appenrodt, Tilman Sauerbruch, Susceptibility to spontaneous bacterial peritonitis - are genetics the future?, Liver International, 2012, 32, 2
  23. 23
    Charanjit Virk, Nayantara Coelho-Prabhu, Navtej S. Buttar, Clinical Gastrointestinal Endoscopy, 2012,

    CrossRef

  24. 24
    Matthew J. Weiss, Blumgart's Surgery of the Liver, Pancreas and Biliary Tract, 2012,

    CrossRef

  25. 25
    Thierry Thevenot, Jean-Paul Cervoni, Vincent Di Martino, Bêtabloquants dans l’hypertension portale : des restrictions inattendues !, La Presse Médicale, 2011, 40, 3, 227

    CrossRef

  26. 26
    Len Verbeke, Frederik Nevens, Wim Laleman, Bench-to-beside review: Acute-on-chronic liver failure - linking the gut, liver and systemic circulation, Critical Care, 2011, 15, 5, 233

    CrossRef

  27. 27
    Pia Afzelius, Nassim Bazeghi, Peter Bie, Flemming Bendtsen, Jørgen Vestbo, Søren Møller, Circulating nitric oxide products do not solely reflect nitric oxide release in cirrhosis and portal hypertension, Liver International, 2011, 31, 9
  28. 28
    Oscar Esparcia, Michel Montemayor, Gemma Ginovart, Virginia Pomar, Germán Soriano, Roser Pericas, Mercedes Gurgui, Elena Sulleiro, Guillem Prats, Ferran Navarro, Pere Coll, Diagnostic accuracy of a 16S ribosomal DNA gene-based molecular technique (RT-PCR, microarray, and sequencing) for bacterial meningitis, early-onset neonatal sepsis, and spontaneous bacterial peritonitis, Diagnostic Microbiology and Infectious Disease, 2011, 69, 2, 153

    CrossRef

  29. 29
    Jonel Trebicka, Aleksander Krag, Stefan Gansweid, Beate Appenrodt, Peter Schiedermaier, Tilman Sauerbruch, Ulrich Spengler, Endotoxin and tumor necrosis factor-receptor levels in portal and hepatic vein of patients with alcoholic liver cirrhosis receiving elective transjugular intrahepatic portosystemic shunt, European Journal of Gastroenterology & Hepatology, 2011, 23, 12, 1218

    CrossRef

  30. 30
    Arthur W. Yan, Derrick E. Fouts, Johannes Brandl, Peter Stärkel, Manolito Torralba, Eckart Schott, Hide Tsukamoto, Karen E. Nelson, David A. Brenner, Bernd Schnabl, Enteric dysbiosis associated with a mouse model of alcoholic liver disease, Hepatology, 2011, 53, 1
  31. 31
    Felix Gundling, Fabian Schmidtler, Alexander Hapfelmeier, Benjamin Schulte, Thomas Schmidt, Christian Pehl, Wolfgang Schepp, Holger Seidl, Fecal calprotectin is a useful screening parameter for hepatic encephalopathy and spontaneous bacterial peritonitis in cirrhosis, Liver International, 2011, 31, 9
  32. 32
    Claudia Cesaro, Angelo Tiso, Anna Del Prete, Rita Cariello, Concetta Tuccillo, Gaetano Cotticelli, Camillo del Vecchio Blanco, Carmelina Loguercio, Gut microbiota and probiotics in chronic liver diseases, Digestive and Liver Disease, 2011, 43, 6, 431

    CrossRef

  33. 33
    Alexander R. Bonnel, Chalermrat Bunchorntavakul, K. Rajender Reddy, Immune Dysfunction and Infections in Patients With Cirrhosis, Clinical Gastroenterology and Hepatology, 2011, 9, 9, 727

    CrossRef

  34. 34
    Massimo Pinzani, Matteo Rosselli, Michele Zuckermann, Liver cirrhosis, Best Practice & Research Clinical Gastroenterology, 2011, 25, 2, 281

    CrossRef

  35. 35
    Bulent Erenoglu, Huseyin Savas Gokturk, Tevfik Kucukkartallar, Mustafa Sahin, Ahmet Tekin, Yuksel Tatkan, Sait Bodur, Mahmut Baykan, Mechanical intestinal cleansing and antibiotic prophylaxis for preventing bacterial translocation during the pringle maneuver in rabbits, Surgery Today, 2011, 41, 6, 824

    CrossRef

  36. 36
    Zsuzsanna Vitalis, Istvan Altorjay, Istvan Tornai, Karoly Palatka, Sandor Kacska, Eszter Palyu, David Tornai, Miklos Udvardy, Jolan Harsfalvi, Tamas Dinya, Gabor Veres, Peter Laszlo Lakatos, Maria Papp, Phenotypic polymorphism of haptoglobin: A novel risk factor for the development of infection in liver cirrhosis, Human Immunology, 2011, 72, 4, 348

    CrossRef

  37. 37
    Anna Iacono, Giuseppina Mattace Raso, Roberto Berni Canani, Antonio Calignano, Rosaria Meli, Probiotics as an emerging therapeutic strategy to treat NAFLD: focus on molecular and biochemical mechanisms, The Journal of Nutritional Biochemistry, 2011, 22, 8, 699

    CrossRef

  38. 38
    Chih-Huang Li, Ruey-Bing Yang, Jong-Hwei S. Pang, Shy-Shin Chang, Chih-Chuan Lin, Chien-Hsiun Chen, Hsien-Yi Chen, Te-Fa Chiu, Procalcitonin as a Biomarker for Bacterial Infections in Patients With Liver Cirrhosis in the Emergency Department, Academic Emergency Medicine, 2011, 18, 2
  39. 39
    Peter Laszlo Lakatos, Maria Papp, Florian Rieder, Serologic Antiglycan Antibodies in Inflammatory Bowel Disease, The American Journal of Gastroenterology, 2011, 106, 3, 406

    CrossRef

  40. 40
    T. Bruns, J. Peter, S. Hagel, A. Herrmann, A. Stallmach, The augmented neutrophil respiratory burst in response to Escherichia coli is reduced in liver cirrhosis during infection, Clinical & Experimental Immunology, 2011, 164, 3
  41. 41
    Daniel Benten, Julian Wiesch, Karsten Sydow, Andreas Koops, Peter Buggisch, Rainer H Böger, Charlotte A Gaydos, Helen Won, Veronica Franco, Ansgar W Lohse, Stuart C Ray, Ashwin Balagopal, The transhepatic endotoxin gradient is present despite liver cirrhosis and is attenuated after transjugular portosystemic shunt (TIPS)., BMC Gastroenterology, 2011, 11, 1, 107

    CrossRef

  42. 42
    H.D. Nischalke, C. Berger, K. Aldenhoff, L. Thyssen, M. Gentemann, F. Grünhage, F. Lammert, J. Nattermann, T. Sauerbruch, U. Spengler, B. Appenrodt, Toll-like receptor (TLR) 2 promoter and intron 2 polymorphisms are associated with increased risk for spontaneous bacterial peritonitis in liver cirrhosis, Journal of Hepatology, 2011, 55, 5, 1010

    CrossRef

  43. 43
    Lee M. Bass, David M. Steinhorn, Pediatric Critical Care, 2011,

    CrossRef

  44. 44
    Vanessa Stadlbauer, Naina Shah, Montserrat Montes De Oca Arjona, Rajeshwar Prosad Mookerjee, Rajiv Jalan, Alcohol takes the toll on immune function, Liver International, 2010, 30, 7
  45. 45
    Young Seok Kim, Ascites, Hepatorenal Syndrome and Spontaneous Bacterial Peritonitis in Patients with Portal Hypertension, The Korean Journal of Gastroenterology, 2010, 56, 3, 168

    CrossRef

  46. 46
    Pedro Pimentel-Nunes, Roberto Roncon-Albuquerque, Nádia Gonçalves, Cátia Fernandes-Cerqueira, Hélder Cardoso, Rui Pedro Bastos, Margarida Marques, Cristina Marques, José Alexandre Sarmento, Carlos Costa-Santos, Guilherme Macedo, Manuel Pestana, Mário Dinis-Ribeiro, Adelino F. Leite-Moreira, Attenuation of toll-like receptor 2-mediated innate immune response in patients with alcoholic chronic liver disease, Liver International, 2010, 30, 7
  47. 47
    Petros Ypsilantis, Maria Panopoulou, Maria Lambropoulou, Christina Tsigalou, Michail Pitiakoudis, Ioannis Tentes, Sofia Kartali, Fotini Papachristou, Nikolaos Papadopoulos, Constantinos Simopoulos, Bacterial Translocation in a Rat Model of Large Volume Hepatic Radiofrequency Ablation, Journal of Surgical Research, 2010, 161, 2, 250

    CrossRef

  48. 48
    Deepak Venkat, K. K. Venkat, Hepatorenal Syndrome, Southern Medical Journal, 2010, 103, 7, 654

    CrossRef

  49. 49
    Javier Fernández, Vicente Arroyo, Insuficiencia hepática crónica: una entidad clínica necesitada de investigadores, Gastroenterología y Hepatología, 2010, 33, 9, 619

    CrossRef

  50. 50
    Wei Zhang, Yurong Gu, Youming Chen, Hong Deng, Lubiao Chen, Sui Chen, Genglin Zhang, Zhiliang Gao, Intestinal flora imbalance results in altered bacterial translocation and liver function in rats with experimental cirrhosis, European Journal of Gastroenterology & Hepatology, 2010, 1

    CrossRef

  51. 51
    Beate Appenrodt, Lutz E. Lehmann, Lydia Thyssen, Martin Gentemann, Christian Rabe, Ernst Molitor, Jonel Trebicka, Frank Stüber, Tilman Sauerbruch, Is detection of bacterial DNA in ascitic fluid of clinical relevance?, European Journal of Gastroenterology & Hepatology, 2010, 22, 12, 1487

    CrossRef

  52. 52
    Amy N. Sussman, Thomas D. Boyer, Management of Refractory Ascites and Hepatorenal Syndrome, Current Gastroenterology Reports, 2010, 13, 1, 17

    CrossRef

  53. 53
    Sébastien Dharancy, Mathilde Body–Malapel, Alexandre Louvet, Dominique Berrebi, Emilie Gantier, Philippe Gosset, Jérôme Viala, Antoine Hollebecque, Christophe Moreno, Dana J. Philpott, Stephen E. Girardin, Philippe J. Sansonetti, Pierre Desreumaux, Philippe Mathurin, Laurent Dubuquoy, Neutrophil Migration During Liver Injury Is Under Nucleotide-Binding Oligomerization Domain 1 Control, Gastroenterology, 2010, 138, 4, 1546

    CrossRef

  54. 54
    Beate Appenrodt, Frank Grünhage, Martin G. Gentemann, Lydia Thyssen, Tilman Sauerbruch, Frank Lammert, Nucleotide-binding oligomerization domain containing 2 (NOD2) variants are genetic risk factors for death and spontaneous bacterial peritonitis in liver cirrhosis, Hepatology, 2010, 51, 4
  55. 55
    Petros Ypsilantis, Maria Lambropoulou, Anastasia Grapsa, Ioannis Tentes, Christina Tsigalou, Maria Panopoulou, Constantinos Simopoulos, Pringle Maneuver Deteriorates Gut Barrier Dysfunction Induced by Extended-Liver Radiofrequency Ablation, Digestive Diseases and Sciences, 2010, 56, 5, 1548

    CrossRef

  56. 56
    Pablo Bellot, Neftalí Jara Pérez López, Belén Martínez Moreno, José Such, Problemas actuales en la prevención y tratamiento de las infecciones en pacientes con cirrosis, Gastroenterología y Hepatología, 2010, 33, 10, 729

    CrossRef

  57. 57
    Rocío Caño, Lucía Llanos, Pedro Zapater, Sonia Pascual, Pablo Bellot, Claudia Barquero, Miguel Pérez-Mateo, José Such, Rubén Francés, Proteomic evidence of bacterial peptide translocation in afebrile patients with cirrhosis and ascites, Journal of Molecular Medicine, 2010, 88, 5, 487

    CrossRef

  58. 58
    Elsa Solà, Pere Ginès, Renal and circulatory dysfunction in cirrhosis: Current management and future perspectives, Journal of Hepatology, 2010, 53, 6, 1135

    CrossRef

  59. 59
    H.E. Wasmuth, C. Trautwein, Spontan bakterielle Peritonitis bei Leberzirrhose, Intensivmedizin und Notfallmedizin, 2010, 47, 8, 571

    CrossRef

  60. 60
    Lívia G Ferreira, Lucilene R Anastácio, Maria Isabel Correia, The impact of nutrition on cirrhotic patients awaiting liver transplantation, Current Opinion in Clinical Nutrition and Metabolic Care, 2010, 13, 5, 554

    CrossRef

  61. 61
    João-Bruno Soares, Pedro Pimentel-Nunes, Roberto Roncon-Albuquerque, Adelino Leite-Moreira, The role of lipopolysaccharide/toll-like receptor 4 signaling in chronic liver diseases, Hepatology International, 2010, 4, 4, 659

    CrossRef

  62. 62
    Michael R. Lucey, Philippe Mathurin, Timothy R. Morgan, Alcoholic Hepatitis, New England Journal of Medicine, 2009, 360, 26, 2758

    CrossRef

  63. 63
    Wei Hou, Arun J. Sanyal, Ascites: Diagnosis and Management, Medical Clinics of North America, 2009, 93, 4, 801

    CrossRef

  64. 64
    Dae Won Jun, Kyung Tae Kim, Oh Young Lee, Jeong Don Chae, Byoung Kwan Son, Seong Hwan Kim, Yun Ju Jo, Young Sook Park, Association Between Small Intestinal Bacterial Overgrowth and Peripheral Bacterial DNA in Cirrhotic Patients, Digestive Diseases and Sciences, 2009, 55, 5, 1465

    CrossRef

  65. 65
    Seong-Ho Choi, Hyun-Gu Park, Jae Bum Jun, Sang-Oh Lee, Sang-Ho Choi, Jun Hee Woo, Yang Soo Kim, Clinical characteristics and outcomes of pneumococcal bacteremia in adult patients with liver cirrhosis, Diagnostic Microbiology and Infectious Disease, 2009, 63, 2, 160

    CrossRef

  66. 66
    Jeong Heo, Yeon Seok Seo, Hyung Joon Yim, Taeho Hahn, Sang Hoon Park, Sang Hoon Ahn, Jun Yong Park, Ji Young Park, Moon Young Kim, Sung Keun Park, Mong Cho, Soon Ho Um, Kwang Hyub Han, Hong Soo Kim, Soon Koo Baik, Byung Ik Kim, Se Hyun Cho, Clinical Features and Prognosis of Spontaneous Bacterial Peritonitis in Korean Patients with Liver Cirrhosis: A Multicenter Retrospective Study, Gut and Liver, 2009, 3, 3, 197

    CrossRef

  67. 67
    Yasemen Eroglu, William J. Byrne, Hepatic Encephalopathy, Emergency Medicine Clinics of North America, 2009, 27, 3, 401

    CrossRef

  68. 68
    Shey-Ying Chen, Chu-Lin Tsai, Chien-Hao Lin, Chien-Chang Lee, Wen-Chu Chiang, Jiun-Ling Wang, Matthew Huei-Ming Ma, Shyr-Chyr Chen, Wen-Jone Chen, Shan-Chwen Chang, Impact of liver cirrhosis on mortality in patients with community-acquired bacteremia, Diagnostic Microbiology and Infectious Disease, 2009, 64, 2, 124

    CrossRef

  69. 69
    Roberto Tarquini, Emanuela Masini, Giorgio La Villa, Giuseppe Barletta, Marco Novelli, Rosanna Mastroianni, Roberto Giulio Romanelli, Francesco Vizzutti, Ugo Santosuosso, Giacomo Laffi, Increased Plasma Carbon Monoxide in Patients With Viral Cirrhosis and Hyperdynamic Circulation, The American Journal of Gastroenterology, 2009, 104, 4, 891

    CrossRef

  70. 70
    Emidio Scarpellini, Venanzio Valenza, Maurizio Gabrielli, Ernesto Cristiano Lauritano, Germano Perotti, Giuseppe Merra, Antonio Dal Lago, Veronica Ojetti, Maria Elena Ainora, Michele Santoro, Giovanni Ghirlanda, Antonio Gasbarrini, Intestinal Permeability in Cirrhotic Patients With and Without Spontaneous Bacterial Peritonitis: Is the Ring Closed?, The American Journal of Gastroenterology, 2009, 105, 2, 323

    CrossRef

  71. 71
    Ming-Hung Tsai, Yun-Shing Peng, Yung-Chang Chen, Jau-Min Lien, Ya-Chung Tian, Ji-Tseng Fang, Hsu-Huei Weng, Pang-Chi Chen, Chih-Wei Yang, Cheng-Shyong Wu, Low serum concentration of apolipoprotein A-I is an indicator of poor prognosis in cirrhotic patients with severe sepsis, Journal of Hepatology, 2009, 50, 5, 906

    CrossRef

  72. 72
    Andrea T. Borchers, Carlo Selmi, Frederick J. Meyers, Carl L. Keen, M. Eric Gershwin, Probiotics and immunity, Journal of Gastroenterology, 2009, 44, 1, 26

    CrossRef

  73. 73
    Gábor Lakatos, Zsolt Tulassay, Probiotikumok emésztőszervi betegségekben, Orvosi Hetilap, 2009, 150, 19, 883

    CrossRef

  74. 74
    Pere Ginès, Robert W. Schrier, Renal Failure in Cirrhosis, New England Journal of Medicine, 2009, 361, 13, 1279

    CrossRef

  75. You have free access to this content75
    C. PANDE, A. KUMAR, S. K. SARIN, Small-intestinal bacterial overgrowth in cirrhosis is related to the severity of liver disease, Alimentary Pharmacology & Therapeutics, 2009, 29, 12
  76. 76
    Bettina Leber, Ursula Mayrhauser, Michael Rybczynski, Vanessa Stadlbauer, Störungen des angeborenen Immunsystems bei akuten und chronischen Lebererkrankungen, Wiener klinische Wochenschrift, 2009, 121, 23-24, 732

    CrossRef

  77. 77
    Andrew Szilagyi, Handbook of Prebiotics and Probiotics Ingredients, 2009,

    CrossRef

  78. 78
    Bernd Schnabl, Katharina Brandl, Marina Fink, Philipp Gross, Kojiro Taura, Erwin Gäbele, Claus Hellerbrand, Werner Falk, A TLR4/MD2 fusion protein inhibits LPS-induced pro-inflammatory signaling in hepatic stellate cells, Biochemical and Biophysical Research Communications, 2008, 375, 2, 210

    CrossRef

  79. 79
    Rubén Francés, Pedro Zapater, José M. González-Navajas, Carlos Muñoz, Rocío Caño, Rocío Moreu, Sonia Pascual, Pablo Bellot, Miguel Pérez-Mateo, José Such, Bacterial DNA in patients with cirrhosis and noninfected ascites mimics the soluble immune response established in patients with spontaneous bacterial peritonitis, Hepatology, 2008, 47, 3
  80. 80
    Andres T. Blei, Brain Edema in Acute Liver Failure, Critical Care Clinics, 2008, 24, 1, 99

    CrossRef

  81. 81
    Vanessa Stadlbauer, Rajeshwar P. Mookerjee, Stephen Hodges, Gavin A.K. Wright, Nathan A. Davies, Rajiv Jalan, Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosis, Journal of Hepatology, 2008, 48, 6, 945

    CrossRef

  82. 82
    Mike A. Leonis, William F. Balistreri, Evaluation and Management of End-Stage Liver Disease in Children, Gastroenterology, 2008, 134, 6, 1741

    CrossRef

  83. 83
    Tetsuji Fujita, Is bacterial DNA a surrogate marker of bacterial translocation in cirrhosis?, Journal of Hepatology, 2008, 49, 1, 145

    CrossRef

  84. 84
    Alastair O'Brien, Roger Williams, Nutrition in End-Stage Liver Disease: Principles and Practice, Gastroenterology, 2008, 134, 6, 1729

    CrossRef

  85. 85
    Søren Møller, Jens H. Henriksen, Flemming Bendtsen, Pathogenetic background for treatment of ascites and hepatorenal syndrome, Hepatology International, 2008, 2, 4, 416

    CrossRef

  86. 86
    Arun J. Sanyal, Jaime Bosch, Andres Blei, Vincente Arroyo, Portal Hypertension and Its Complications, Gastroenterology, 2008, 134, 6, 1715

    CrossRef

  87. 87
    Anish A. Sheth, Guadalupe Garcia-Tsao, Probiotics and Liver Disease, Journal of Clinical Gastroenterology, 2008, 42, Supplement 2, S80

    CrossRef

  88. 88
    H. Baker, B. Day, Probiotics: where are they going next? New and emerging areas of research, Nutrition Bulletin, 2008, 33, 4
  89. 89
    Ekihiro Seki, David A. Brenner, Toll-like receptors and adaptor molecules in liver disease: Update, Hepatology, 2008, 48, 1
  90. 90
    Reiner Wiest, Lukas Moleda, Bettina Zietz, Claus Hellerbrand, Jürgen Schölmerich, Rainer Straub, Uncoupling of sympathetic nervous system and hypothalamic-pituitary-adrenal axis in cirrhosis, Journal of Gastroenterology and Hepatology, 2008, 23, 12
  91. 91
    Marie-Noëlle Pépin, Pere Ginès, Therapy in Nephrology & Hypertension, 2008,

    CrossRef

  92. 92
    Rubén Francés, José M. González-Navajas, Pedro Zapater, Carlos Muñoz, Rocío Caño, Sonia Pascual, Dorkas Márquez, Francia Santana, Miguel Pérez-Mateo, José Such, Bacterial DNA Induces the Complement System Activation in Serum and Ascitic Fluid from Patients with Advanced Cirrhosis, Journal of Clinical Immunology, 2007, 27, 4, 438

    CrossRef

  93. 93
    Leonidas Christou, Georgios Pappas, Matthew E. Falagas, Bacterial Infection-Related Morbidity and Mortality in Cirrhosis, The American Journal of Gastroenterology, 2007, 102, 7, 1510

    CrossRef

  94. 94
    A. Milani, R. Zaccaria, G. Bombardieri, A. Gasbarrini, P. Pola, Cirrhotic cardiomyopathy, Digestive and Liver Disease, 2007, 39, 6, 507

    CrossRef

  95. 95
    Vanessa Stadlbauer, Nathan A. Davies, Gavin A.K. Wright, Rajeshwar P. Mookerjee, Rajiv Jalan, Endotoxemia during liver transplantation, Liver Transplantation, 2007, 13, 11
  96. 96
    M. Ortega, M. Almela, J. A. Martinez, F. Marco, A. Soriano, J. López, M. Sánchez, A. Muñoz, J. Mensa, Epidemiology and outcome of primary community-acquired bacteremia in adult patients, European Journal of Clinical Microbiology & Infectious Diseases, 2007, 26, 7, 453

    CrossRef

  97. 97
    Ayman Samir Farid, Fumiko Jimi, Kyoko Inagaki-Ohara, Yoichiro Horii, INCREASED INTESTINAL ENDOTOXIN ABSORPTION DURING ENTERIC NEMATODE BUT NOT PROTOZOAL INFECTIONS THROUGH A MAST CELL-MEDIATED MECHANISM, Shock, 2007, 1

    CrossRef

  98. 98
    Jérôme Boursier, Pierre Asfar, Marie-Laure Joly-Guillou, Paul Calès, Infection et rupture de varice œsophagienne au cours de la cirrhose, Gastroentérologie Clinique et Biologique, 2007, 31, 1, 27

    CrossRef

  99. 99
    Rekha Cheruvattath, Vijayan Balan, Infections in Patients With End-stage Liver Disease, Journal of Clinical Gastroenterology, 2007, 41, 4, 403

    CrossRef

  100. 100
    Pablo Palma, Nicolas Mihaljevic, Till Hasenberg, Michael Keese, Thomas A. Koeppel, Intestinal barrier dysfunction in developing liver cirrhosis: An in vivo analysis of bacterial translocation, Hepatology Research, 2007, 37, 1
  101. 101
    Jeong Heo, Soon Ho Um, Microbiological Characteristics of Spontaneous Bacterial Peritonitis in Korea, The Korean Journal of Hepatology, 2007, 13, 3, 304

    CrossRef

  102. 102
    M. Odeh, Pathogenesis of hepatic encephalopathy: the tumour necrosis factor-α theory, European Journal of Clinical Investigation, 2007, 37, 4
  103. 103
    Stéphane M. Schneider, Sarah Giudicelli, Probiotiques Et Autres Pathologies Digestives : Perspectives, Cahiers de Nutrition et de Diététique, 2007, 42, 60

    CrossRef

  104. 104
    M. Odeh, Relationship between circulating levels of tumour necrosis factor-α and Child–Pugh scores in liver cirrhosis, International Journal of Clinical Practice, 2007, 61, 3
  105. 105
    P.F. McAULIFFE, L.L. MOLDAWER, Surgery of the Liver, Biliary Tract and Pancreas, 2007,

    CrossRef

  106. 106
    Ming-Hung Tsai, Yun-Shing Peng, Yung-Chang Chen, Nai-Jeng Liu, Yu-Pin Ho, Ji-Tseng Fang, Jau-Min Lien, Chun Yang, Pang-Chi Chen, Cheng-Shyong Wu, Adrenal insufficiency in patients with cirrhosis, severe sepsis and septic shock, Hepatology, 2006, 43, 4
  107. 107
    Ali R Mani, Reza Rasool, Sara Montagnese, Ahmad R Dehpour, Endogenous opioids and liver disease, Scandinavian Journal of Gastroenterology, 2006, 41, 1, 1

    CrossRef

  108. 108
    Lee-Wei Chen, Hau-Lun Huang, I-Te Lee, Ching-Mei Hsu, Pei-Jung Lu, Hypertonic saline enhances host defense to bacterial challenge by augmenting Toll-like receptors*, Critical Care Medicine, 2006, 34, 6, 1758

    CrossRef

  109. 109
    Guadalupe Garcia-Tsao, Portal hypertension, Current Opinion in Internal Medicine, 2006, 5, 4, 399

    CrossRef

  110. 110
    Carlos Guarner, José M. González-Navajas, Elisabet Sánchez, Germán Soriando, Rubén Francés, Maite Chiva, Pedro Zapater, Susana Benlloch, Carlos Muñoz, Sonia Pascual, Joaquín Balanzó, Miguel Pérez-Mateo, José Such, The detection of bacterial DNA in blood of rats with CCl4-induced cirrhosis with ascites represents episodes of bacterial translocation, Hepatology, 2006, 44, 3
  111. 111
    Stephen M. Riordan, Roger Williams, The intestinal flora and bacterial infection in cirrhosis, Journal of Hepatology, 2006, 45, 5, 744

    CrossRef

  112. 112
    Philip A Berry, Julia A Wendon, The management of severe alcoholic liver disease and variceal bleeding in the intensive care unit, Current Opinion in Internal Medicine, 2006, 5, 3, 276

    CrossRef

  113. 113
    Robert F. Schwabe, Ekihiro Seki, David A. Brenner, Toll-Like Receptor Signaling in the Liver, Gastroenterology, 2006, 130, 6, 1886

    CrossRef

  114. 114
    Ying-Ying Yang, Han-Chieh Lin, Bacterial Infections in Patients with Cirrhosis, Journal of the Chinese Medical Association, 2005, 68, 10, 447

    CrossRef